Moderna (NASDAQ:MRNA – Get Free Report) had its price objective lowered by analysts at JPMorgan Chase & Co. from $40.00 to ...

Shares of Moderna, Inc. (NASDAQ:MRNA – Get Free Report) have been assigned an average rating of “Hold” from the twenty-four ...

Consistent in their evaluation, an analyst from UBS keeps a Buy rating on Moderna with a target price of $78. * In a cautious move, an analyst from Goldman Sachs downgraded its rating to Neutral ...

Goldman Sachs named David Dubner as chief operating officer of global mergers and acquisitions, according to a memo seen by Reuters on Wednesday, beefing up leadership in one of its most important ...

The financial services giant Goldman Sachs is telling shareholders that its competitors are now offering crypto products and ...